Three were randomized, double-blind, placebo-controlled trials, including 16 weeks of dose increases, and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients assigned semaglutide either continued treatment or switched to a placebo
one such factor, insufficiently studied, is drug-physiology interactions in patient populations whose autonomic or connective tissue biology was not represented in the populations that generated the efficacy data
That could mean as many as 20 million Americans already are using GLP-1s, and subsequently benefiting from lower colon cancer risk
It helps increase bile acid secretion to help with peristalsis
But here is the tricky part: early-stage degradation may not produce any visible changes